SEC 13F Intelligence

Atwood & Palmer Inc / ABBV

Atwood & Palmer Inc’s Abbvie Inc Position

Does Atwood & Palmer Inc own Abbvie Inc (ABBV)? Yes195.8K shares worth $49M (+2.63% of its 13F portfolio) as of Q2 2026, up from 194.1K shares the prior filed quarter.

Position Value
$49M
Q2 2026
Shares
195.8K
% of Portfolio
+2.63%
Quarters Held
31
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $230,000Q4 ’18Q1 ’19: $201,000Q2 ’19: $182,000Q3 ’19: $189,000Q4 ’19: $221,000Q4 ’19Q1 ’20: $214,000Q2 ’20: $12MQ3 ’20: $11MQ4 ’20: $15MQ4 ’20Q1 ’21: $15MQ2 ’21: $17MQ3 ’21: $17MQ4 ’21: $22MQ4 ’21Q1 ’22: $26MQ2 ’22: $28MQ3 ’22: $24MQ4 ’22: $30MQ4 ’22Q1 ’23: $30MQ2 ’23: $25MQ3 ’23: $28MQ4 ’23: $29MQ4 ’23Q1 ’24: $35MQ2 ’24: $33MQ3 ’24: $38MQ4 ’24: $35MQ4 ’24Q1 ’25: $40MQ2 ’25: $35MQ3 ’25: $44MQ4 ’25: $44MQ4 ’25Q1 ’26: $42MQ2 ’26: $49Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 2026195.8K$49M+2.63%
Q1 2026194.1K$42M+2.38%
Q4 2025194.4K$44M+2.52%
Q3 2025190.9K$44M+2.60%
Q2 2025190.8K$35M+2.21%
Q1 2025191.3K$40M+2.78%
Q4 2024195.9K$35M+2.39%
Q3 2024193.5K$38M+2.60%
Q2 2024194.2K$33M+2.52%
Q1 2024190.4K$35M+2.63%
Q4 2023189.3K$29M+2.37%
Q3 2023189.8K$28M+2.48%
Q2 2023189.2K$25M+2.28%
Q1 2023186.1K$30M+2.79%
Q4 2022184.6K$30M+2.70%
Q3 2022182.4K$24M+2.43%
Q2 2022179.9K$28M+2.68%
Q1 2022162.6K$26M+2.28%
Q4 2021159.2K$22M+1.80%
Q3 2021158.4K$17M+1.52%
Q2 2021150.7K$17M+1.53%
Q1 2021139.5K$15M+1.45%
Q4 2020137.7K$15M+1.58%
Q3 2020127.6K$11M+1.41%
Q2 2020126.2K$12M+1.67%
Q1 20202.8K$214,000+0.03%
Q4 20192.5K$221,000+0.03%
Q3 20192.5K$189,000+0.03%
Q2 20192.5K$182,000+0.02%
Q1 20192.5K$201,000+0.03%
Q4 20182.5K$230,000+0.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Atwood & Palmer Inc’s full portfolio or all institutional holders of ABBV.